D-0798-2020 Class II Terminated

Recalled by RemedyRepack Inc. — Indiana, PA

FDA drug recall D-0798-2020 was initiated by RemedyRepack Inc. on Dec 11, 2019 and is designated Class II. Reason for recall: CGMP Deviation; Received notice from supplier of potential -Nitrosodimethylamine (NDMA) amounts above established levels. The recall status is terminated (terminated Jul 23, 2020). Affected quantity: 4,486 tablets.

Recall details

Product Type
Drugs
Report Date
Jan 29, 2020
Initiation Date
Dec 11, 2019
Termination Date
Jul 23, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4,486 tablets

Product description

Ranitidine 150 mg tablet Original Supplier's NDC 65162-0253-10 Remedy Repackaged NDC 70518-1714-00

Reason for recall

CGMP Deviation; Received notice from supplier of potential -Nitrosodimethylamine (NDMA) amounts above established levels.

Distribution pattern

Product was distributed to two facilities in CA and NY.

Code information

Lot #: J0376034-052319, exp. date 05/2020 Lot #: J0406133-093019, exp. date 10/2020 Lot #: J038005-082719, exp. date 08/2020 Lot #: J0390280-072519, exp. date 07/2020 Lot #: J0390277-072519, exp. date 07/2020 Lot #: J0349352-012519, exp. date 01/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0798-2020
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0798-2020. Report a data issue: hello@regdatalab.com.